
Worldwide prevalence of sporadic colorectal cancer— long viewed as a disease of older individuals — has increased steadily among those aged younger than 50 years during the past decade, according to a review paper in The Lancet Oncology.
“This review is one of three papers The Lancet decided to focus on regarding the early-onset colorectal cancer patient population,” Cathy Eng, MD, FACP, FASCO, David H. Johnson endowed chair in the division of surgical and medical oncology and professor of medicine in the department of hematology and oncology at Vanderbilt University